Kidney disease means your kidneys are damaged and can’t filter blood the way they should. Those with diabetes or high blood pressure are at greater risk of developing kidney disease.
Kidney problems include acute kidney injury, chronic kidney disease, kidney cysts, kidney stones, and kidney infections.
The ISN and The Transplantation Society (TTS) are pleased to announce that four newly formed partnerships have been accepted into the joint ISN-TTS Sister Transplant Centers (STC) Program. In addition, one partnership has successfully upgraded to Level A and four partnerships to Level B. One partnership has successfully graduated. The Southern Philippines Medical Center Kidney Transplant...
The next #NephTrials will be held on March 10, 2023, at 3 p.m. CET! Join Ron Gansevoort, primary investigator of the RENAL LIFECYCLE trial, in conversation with Michael Walsh, Roberto Pecoits-Filho, Joel Topf, Manasi Bapat, and Swapnil Hiremath. The panel will examine the composite and secondary outcomes of a randomized control trial investigating the effects...
Kidney International: Results From Part A of the Multi-center, Double-blind, Randomized, Placebo-controlled Nefigard Trial, Which Evaluated Targeted-release Formulation of Budesonide for the Treatment of Primary Immunoglobulin A Nephropathy To verify the findings of the 2b NEFIGAN trial, the phase 3 NefigArd trial tested the efficacy and safety of nine months of treatment with Nefecon® versus placebo...
An editorial by ISN President Professor Agnes Fogo has been published in the winter edition of the Journal of the American Association of Physicians of Indian Origin (JAAPI). Read the open-access article here. "Kidney Disease: The Silent Killer That Needs Our Voice" includes the most recent data on the burden of kidney disease, raising awareness of...
Two classic films are now available to watch on the ISN Academy: "The Human Kidney: Tubules, Blood Vessels and Vascular-Tubular Relations" and "The Vascular and Tubular Organization of the (Dog) Kidney" These historical, yet clinically still relevant, films were independently produced in 1975 by members of the Department of Physiology at Harvard Medical School.* They illustrate the highly...
IgA nephropathy is one of the most common glomerular diseases, worldwide. The diagnostic histologic hallmark is dominant or codominant IgA staining on kidney biopsy; however, patients may present with various clinical syndromes ranging from asymptomatic abnormalities noted on urinalysis, nephritic syndrome, nephrotic-nephritic syndrome to rapidly progressive glomerulonephritis with crescentic transformation. There is substantial heterogeneity in the...
Did you miss the live session of the ISN Webinar "Mixed Methods Research in Kidney Care"? Watch the recording here. Moderators Fergus Caskey, Pippa Bailey, and Masaomi Nangaku joined speakers Alicia O’Cathain and Lilia Cervantes in an interactive discussion on mixing qualitative and quantitative research methods within a single kidney care study. The event generated much...
The webinar, “Pros and Cons of Public-Private Partnerships in Developing Dialysis Services in Resource-limited Settings,” will take place on February 9, 2023, from 2-3 p.m. CET. The webinar is part of the ISN-WHO "Toolkit for Dialysis in Low-resource Settings" and complements the ISN-WHO framework for developing dialysis in low-resource settings. The event is led...
Uncovering Risk Factors for Kidney Injury in Children With a Solitary Functioning Kidney A nationwide, multicenter study of children diagnosed with congenital or acquired solitary functioning kidney before adulthood indicates that a significant proportion will develop kidney injury over time, with kidney agenesis and being overweight as principal risk factors. Long-term Outcomes of Children and Adolescents...
On behalf of the Australasian Kidney Trials Network Survey, patients, caregivers and health professionals are invited to complete a global survey to help identify important things to consider when preventing urine infections in people with kidney transplants. The answers will help design a clinical trial to attain better evidence. The survey takes 8-12 minutes to complete. Take...
The ISN-ACT (Advancing Clinical Trials) has created an online map tracking trial networks in kidney care research around the world. The aim is to facilitate clinical trial capacity and professional exchanges and collaboration by connecting people undertaking clinical trials and related studies in nephrology. The map allows researchers to quickly locate trial networks with the capacity...
Whet your appetite in the run-up to WCN'23 with the first bumper edition of the pre-congress newsletter. Read the pre-congress newsletter here. Highlights include: An interview with Yot Teerawattanon, an HTA expert from Thailand Video interview with WCN'23 scientific program chair and speaker Matthias Kretzler ISN Young Nephrologists on overcoming obstacles to attend the congress and unmissable content A preview...
Lise Bankir, ISN emeritus member and "Directeur de Recherche Emérite" at INSERM (the French Institute of Health and Medical Research), has kindly donated the films: "The Human Kidney: Tubules, Blood Vessels and Vascular-Tubular Relations" and "The Vascular and Tubular Organization of the (Dog) Kidney" Watch the films here. These historical, yet clinically still relevant, films were independently produced in...
Your ISN membership helped the ISN global community to grow and thrive in 2022. Last year, the ISN supported: 23 ISN Fellows 15 ISN Interventional Nephrology scholars 4 ISN Clinical Research Projects 22 Local educational meetings 21 ISN Regional Training Centers 6 ISN Continuing Medical Education meetings 4 ISN Educational Ambassadors 63 ISN Sister Centers pairs 30 ISN Mentorship pairs WCN'22 Two ISN Frontiers Meetings ISN Academy...
"Availability and Prioritization of COVID-19 Vaccines Among Patients With Chronic Kidney Disease and Kidney Transplant - A Global Survey by the International Society of Nephrology" has been published in BMJ Open. Read the manuscript here. The paper is based on a survey initiated by a team of ISN members on the availability, preparation and prioritization of...
The manuscript “Challenges and Opportunities in Interventions for Chronic Kidney Disease of Unknown Origin (CKDu): Report from the International Society of Nephrology Consortium of Collaborators on CKDu” has been published in Kidney International. Read the manuscript here. The paper was drafted after a special ISN i3C Working Group meeting was held to discuss potential interventions in communities...
Read the current issue of the Declaration of Istanbul on Organ Trafficking and Transplant Tourism (DICG) newsletter here. The DICG is a joint initiative of the ISN and The Transplantation Society This edition features: TTS-DICG joint session on "Organ Trade, Trafficking, and Transplant Tourism: Government's and Scientific Societies' Responsibilities” at the "29th International Congress of The Transplant...
Defining Measures of Kidney Function In Observational Studies Using Routine Health Care Data: Methodological and Reporting Considerations This review illustrates the diversity of working definitions of kidney disease in scientific literature and discusses the advantages and limitations of the most commonly used approaches. The authors summarize ways to identify and overcome possible biases and propose a framework...
Watch the videos here. The videos are based on papers from Kidney International and Kidney International Reports: Incidence of New Onset Glomerulonephritis After SARS-CoV-2 mRNA Vaccination Is Not Increased Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-stage Kidney Disease in Lupus Nephritis
The ISN Clinical Research Program (CRP) offers grants to researchers in low, lower-middle, and upper-middle-income countries to support research projects on detecting and managing noncommunicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease. Apply to the program here. Regional coordinators must receive the application by April 1. Final applications are accepted once per...
